These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 30684189)

  • 1. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
    Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
    Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol-related gene variants are associated with diabetes in coronary artery disease patients.
    Ozuynuk AS; Erkan AF; Ekici B; Erginel-Unaltuna N; Coban N
    Mol Biol Rep; 2021 May; 48(5):3945-3954. PubMed ID: 34021444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.
    Chuang WL; Hsieh YC; Wang CY; Kuo HC; Huang CC
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):42-8. PubMed ID: 20145290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SORL1 gene, plasma biomarkers, and the risk of Alzheimer's disease for the Han Chinese population in Taiwan.
    Chou CT; Liao YC; Lee WJ; Wang SJ; Fuh JL
    Alzheimers Res Ther; 2016 Dec; 8(1):53. PubMed ID: 28034305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals.
    Tycko B; Lee JH; Ciappa A; Saxena A; Li CM; Feng L; Arriaga A; Stern Y; Lantigua R; Shachter N; Mayeux R
    Arch Neurol; 2004 Sep; 61(9):1434-9. PubMed ID: 15364690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators.
    Borroni B; Archetti S; Agosti C; Akkawi N; Brambilla C; Caimi L; Caltagirone C; Di Luca M; Padovani A
    Neurobiol Aging; 2004 Jul; 25(6):747-51. PubMed ID: 15165699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease.
    Li L; Yin Z; Liu J; Li G; Wang Y; Yan J; Zhou H
    J Neurol; 2013 Jul; 260(7):1701-8. PubMed ID: 23070465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
    Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
    J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of APOE and SORL1 genes on hippocampal functional connectivity in healthy young adults.
    Shen J; Qin W; Xu Q; Xu L; Xu J; Zhang P; Liu H; Liu B; Jiang T; Yu C
    Brain Struct Funct; 2017 Aug; 222(6):2877-2889. PubMed ID: 28229235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
    Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
    Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population.
    Li Z; Yang N; Lei X; Lin C; Li N; Jiang X; Wei X; Xu B
    J Clin Lab Anal; 2019 Sep; 33(7):e22950. PubMed ID: 31199015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.
    Zhou Q; Zhao F; Lv ZP; Zheng CG; Zheng WD; Sun L; Wang NN; Pang S; de Andrade FM; Fu M; He XH; Hui J; Jiang W; Yang CY; Shi XH; Zhu XQ; Pang GF; Yang YG; Xie HQ; Zhang WD; Hu CY; Yang Z
    PLoS One; 2014; 9(1):e87017. PubMed ID: 24498013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic influences on Alzheimer's disease: evidence of interactions between the genes APOE, APOC1 and ACE in a sample population from the South of Brazil.
    Lucatelli JF; Barros AC; Silva VK; Machado Fda S; Constantin PC; Dias AA; Hutz MH; de Andrade FM
    Neurochem Res; 2011 Aug; 36(8):1533-9. PubMed ID: 21533863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers.
    Alexopoulos P; Guo LH; Kratzer M; Westerteicher C; Kurz A; Perneczky R
    Dement Geriatr Cogn Disord; 2011; 32(3):164-70. PubMed ID: 21997402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese.
    Chen DW; Yang JF; Tang Z; Dong XM; Feng XL; Yu S; Chan P
    Brain Res; 2008 Jan; 1187():52-7. PubMed ID: 18036514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
    Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk.
    Kulminski AM; Philipp I; Shu L; Culminskaya I
    Neurobiol Aging; 2022 Feb; 110():122-131. PubMed ID: 34625307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.